{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Infection&page=18", "query": { "intervention": "Infection", "page": 18 }, "page_size": 10 }, "pagination": { "page": 18, "page_size": 10, "total_count": 5231, "total_pages": 524, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Infection&page=19&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Infection&page=17&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T21:47:36.605Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04376593", "title": "PET/CT Imaging in COVID-19 Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "COVID-19", "SARS-CoV-2 Infection" ], "interventions": [ { "name": "18F-αvβ6-BP", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2020-05-01", "completion_date": "2026-02-23", "has_results": false, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-10-30T21:47:36.605Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04376593" }, { "nct_id": "NCT05000216", "title": "COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis (RA)", "Systemic Lupus Erythematosus (SLE)", "Pemphigus Vulgaris", "Multiple Sclerosis (MS)", "Systemic Sclerosis (SSc)", "Pediatric SLE", "Juvenile Idiopathic Arthritis (JIA)", "Juvenile Dermatomyositis (JDM)", "Pediatric-Onset Multiple Sclerosis (POMS)" ], "interventions": [ { "name": "Moderna mRNA-1273", "type": "BIOLOGICAL" }, { "name": "BNT162b2", "type": "BIOLOGICAL" }, { "name": "Ad26.COV2.S", "type": "BIOLOGICAL" }, { "name": "Continue IS (MMF or MPA)", "type": "DRUG" }, { "name": "Continue IS (MTX)", "type": "DRUG" }, { "name": "Continue IS (B cell depletion therapy)", "type": "BIOLOGICAL" }, { "name": "Monovalent [B.1.351] CoV2 preS dTM-AS03", "type": "BIOLOGICAL" }, { "name": "Withhold IS (MMF or MPA)", "type": "DRUG" }, { "name": "Withhold IS (MTX)", "type": "DRUG" }, { "name": "Withhold IS (B cell depletion therapy)", "type": "DRUG" }, { "name": "Moderna mRNA-1273, Bivalent", "type": "BIOLOGICAL" }, { "name": "BNT162b2, Bivalent", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 258, "start_date": "2021-08-13", "completion_date": "2024-03-28", "has_results": true, "last_update_posted_date": "2026-06-10", "last_synced_at": "2026-10-30T21:47:36.605Z", "location_count": 29, "location_summary": "Los Angeles, California • New Haven, Connecticut • Atlanta, Georgia + 18 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05000216" }, { "nct_id": "NCT02875119", "title": "Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infection" ], "interventions": [ { "name": "Griffithsin Gel", "type": "DRUG" }, { "name": "Placebo Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Population Council", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "FEMALE", "summary": "18 Years to 49 Years · Female only" }, "enrollment_count": 15, "start_date": "2017-10-01", "completion_date": "2018-09-01", "has_results": false, "last_update_posted_date": "2018-11-27", "last_synced_at": "2026-10-30T21:47:36.605Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02875119" }, { "nct_id": "NCT01872936", "title": "Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [ { "name": "Miravirsen", "type": "DRUG" }, { "name": "Telaprevir", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Santaris Pharma A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 20, "start_date": "2013-06", "completion_date": "2015-01", "has_results": false, "last_update_posted_date": "2014-11-18", "last_synced_at": "2026-10-30T21:47:36.605Z", "location_count": 2, "location_summary": "Dallas, Texas • Houston, Texas", "locations": [ { "city": "Dallas", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01872936" }, { "nct_id": "NCT01330316", "title": "A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "BI 201335", "type": "DRUG" }, { "name": "PegIFN/RBV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 119, "start_date": "2011-07", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2016-06-30", "last_synced_at": "2026-10-30T21:47:36.605Z", "location_count": 20, "location_summary": "Birmingham, Alabama • North Little Rock, Arkansas • Los Angeles, California + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "North Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01330316" }, { "nct_id": "NCT02135614", "title": "Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Respiratory Syncytial Virus Infection" ], "interventions": [ { "name": "Presatovir", "type": "DRUG" }, { "name": "Presatovir placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 189, "start_date": "2014-06-09", "completion_date": "2017-04-12", "has_results": true, "last_update_posted_date": "2018-09-24", "last_synced_at": "2026-10-30T21:47:36.605Z", "location_count": 9, "location_summary": "Chicago, Illinois • Annapolis, Maryland • Detroit, Michigan + 6 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Annapolis", "state": "Maryland" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Royal Oak", "state": "Michigan" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02135614" }, { "nct_id": "NCT06469151", "title": "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "AZD5148", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 84, "start_date": "2024-06-24", "completion_date": "2025-10-22", "has_results": false, "last_update_posted_date": "2025-11-10", "last_synced_at": "2026-10-30T21:47:36.605Z", "location_count": 4, "location_summary": "Anniston, Alabama • Glendale, California • Baltimore, Maryland + 1 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Glendale", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06469151" }, { "nct_id": "NCT04804072", "title": "INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections", "Drug Use", "Opioid Use", "Opioid-use Disorder" ], "interventions": [ { "name": "Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)", "type": "DRUG" }, { "name": "HIV testing", "type": "DIAGNOSTIC_TEST" }, { "name": "HIV treatment for participants living with HIV not already in care", "type": "DRUG" }, { "name": "PrEP for participants without HIV", "type": "DRUG" }, { "name": "Testing and referral for vaccination or treatment for hepatitis A virus (HAV) and hepatitis B virus (HBV)", "type": "DIAGNOSTIC_TEST" }, { "name": "Testing and referral for treatment for hepatitis C virus (HCV)", "type": "DIAGNOSTIC_TEST" }, { "name": "Sexually transmitted infection (STI) testing and treatment", "type": "DIAGNOSTIC_TEST" }, { "name": "Primary care", "type": "OTHER" }, { "name": "Harm reduction services", "type": "BEHAVIORAL" }, { "name": "Peer navigation", "type": "BEHAVIORAL" }, { "name": "COVID-19 testing and referral for further evaluation, care and/or treatment", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "OTHER", "BEHAVIORAL" ], "sponsor": "HIV Prevention Trials Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 447, "start_date": "2021-06-02", "completion_date": "2024-12-17", "has_results": true, "last_update_posted_date": "2026-06-10", "last_synced_at": "2026-10-30T21:47:36.605Z", "location_count": 5, "location_summary": "Los Angeles, California • Washington D.C., District of Columbia • The Bronx, New York + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "The Bronx", "state": "New York" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04804072" }, { "nct_id": "NCT00000995", "title": "A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cytomegalovirus Infections", "HIV Infections" ], "interventions": [ { "name": "Zidovudine", "type": "DRUG" }, { "name": "Ganciclovir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": null, "completion_date": "1990-02", "has_results": false, "last_update_posted_date": "2021-11-04", "last_synced_at": "2026-10-30T21:47:36.605Z", "location_count": 3, "location_summary": "San Diego, California • New York, New York • Rochester, New York", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000995" }, { "nct_id": "NCT02570321", "title": "Cross-linking for Corneal Ulcers Treatment Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Corneal Ulcer", "Infectious Keratitis", "Bacterial Ulcer", "Fungal Ulcer" ], "interventions": [ { "name": "Corneal Cross-linking", "type": "PROCEDURE" }, { "name": "Anti Fungal Drug", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 147, "start_date": "2015-11", "completion_date": "2019-03-19", "has_results": true, "last_update_posted_date": "2025-06-18", "last_synced_at": "2026-10-30T21:47:36.605Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02570321" } ] }